| Similar Articles |
|---|
 |
BusinessWeek
October 3, 2005
Gene G. Marcial |
Giant Strides At Symmetry Symmetry Medical is sitting pretty in the fast-growing orthopedics market.   |
The Motley Fool
December 21, 2005
Stephen D. Simpson |
Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note. |
The Motley Fool
May 9, 2005
Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool
October 5, 2005
Stephen D. Simpson |
Wright Goes Wrong A weak third quarter compounds troubles for this pipeline-challenged orthopedics player. There is no compelling reason to purchase this stock today. |
The Motley Fool
May 24, 2006
Stephen D. Simpson |
Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment. |
The Motley Fool
February 4, 2008
Selena Maranjian |
Best International Stock: Flextronics A quick summary of Singapore-based Flextronics, a contract manufacturer of components for electronics companies. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool
April 24, 2006
Stephen D. Simpson |
Kensey Nash: Now the Comeback Kid? Strong results from a new device might be reason for optimism. Investors should still keep an eye on the valuations here and err on the side of cheapness. |
The Motley Fool
September 27, 2005
Stephen D. Simpson |
Not Bracing for the Worst Price competition and tighter reimbursement? dj Orthopedics isn't worrying about them. Investors may not rush to sell, but they should perhaps start thinking about a protective stop-loss to lock on some easy profits. |
The Motley Fool
June 22, 2005
W.D. Crotty |
Jabil's Sparkling Circuits Given its industry environment, the circuit-board maker posted strong operating margins: 3.8% in the latest quarter and 3.5% on a trailing annual basis. Investors, take note. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
The Motley Fool
July 20, 2007
Ryan Fuhrmann |
Stryker Does a Body Good The orthopedics company continues its double-digit growth in an industry with a bright future. Investors, take note. |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool
October 21, 2011
Anders Bylund |
Flextronics International's Shares Popped: What You Need to Know Shares of electronics design and manufacturing specialist Flextronics International flexed their silicon muscles today, jumping as much as 11.1% overnight on several times their average trading volume. |
The Motley Fool
April 13, 2006
Stephen D. Simpson |
A Foolish Baby Shower: Stryker Here is a stock you can be comfortable with buying for your little one with the intention that it would be held for at least 18 years. |
The Motley Fool
March 21, 2006
Stephen D. Simpson |
Biomet's Stiff Joints Pricing isn't collapsing, but the orthopedics company isn't exactly prospering, either. Investors, beware. |
The Motley Fool
April 26, 2005
Stephen D. Simpson |
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. |
The Motley Fool
September 14, 2005
Stephen D. Simpson |
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. |
The Motley Fool
August 2, 2006
Stephen D. Simpson |
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. |
The Motley Fool
August 21, 2006
Stephen D. Simpson |
Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence. |
The Motley Fool
August 23, 2006
Stephen D. Simpson |
Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution. |
The Motley Fool
June 10, 2005
T.G. Wolf |
Greatbatch Finds a Pulse Can this specialist in medical devices be great for investors again? |
The Motley Fool
March 22, 2005
Stephen D. Simpson |
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. |
The Motley Fool
October 31, 2005
Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
